Drug Shortage Report for NOREPINEPHRINE BITARTRATE INJECTION USP
| Report ID | 159100 |
| Drug Identification Number | 00893285 |
| Brand name | NOREPINEPHRINE BITARTRATE INJ 1MG/ML USP |
| Common or Proper name | NOREPINEPHRINE |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | NOREPINEPHRINE |
| Strength(s) | 1MG |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 4ML 10LIV |
| ATC code | C01CA |
| ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2022-09-27 |
| Estimated end date | 2022-10-21 |
| Actual end date | 2022-10-12 |
| Shortage status | Resolved |
| Updated date | 2022-10-13 |
| Company comments | Product is available on allocation at wholesalers, based on 100% of historical volumes. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2022-06-03 | French | Compare |
| v3 | 2022-06-03 | English | Compare |
| v2 | 2022-04-20 | French | Compare |
| v1 | 2022-04-20 | English | Compare |